Lotus Pharmaceuticals, Inc. (LTUS)
- Previous Close
0.0070 - Open
0.0070 - Bid --
- Ask --
- Day's Range
0.0070 - 0.0070 - 52 Week Range
0.0035 - 0.0120 - Volume
975 - Avg. Volume
4,432 - Market Cap (intraday)
834,491 - Beta (5Y Monthly) -0.39
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China. The company is based in Nashville, Tennessee.
lotuspharmaceuticalsusa.com233
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: LTUS
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LTUS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LTUS
Valuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
0.01
Enterprise Value/EBITDA
0.20
Financial Highlights
Profitability and Income Statement
Profit Margin
2.43%
Return on Assets (ttm)
4.56%
Return on Equity (ttm)
1.82%
Revenue (ttm)
71.39M
Net Income Avi to Common (ttm)
1.72M
Diluted EPS (ttm)
-0.0600
Balance Sheet and Cash Flow
Total Cash (mrq)
158.91k
Total Debt/Equity (mrq)
6.22%
Levered Free Cash Flow (ttm)
-5.29M